Skip to content
10-K/A

Annual Report

MARRONE BIO INNOVATIONS INC.

0001493152-22-012535

← back to feed
Filed
May 9, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 25, 2022 182.27M sh
Capex FY 2021 · Dec 31, 2021 $1.09M
Capex FY 2021 · Dec 31, 2020 $559K
Operating Cash Flow FY 2021 · Dec 31, 2021 −$9.96M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$15.96M
Long Term Debt FY 2021 · Dec 31, 2021 $7.69M
Long Term Debt FY 2021 · Dec 31, 2020 $11.48M
Short Term Debt FY 2021 · Dec 31, 2021 $25.91M
Short Term Debt FY 2021 · Dec 31, 2020 $9.3M
Cash And Equivalents FY 2021 · Dec 31, 2021 $19.62M
Cash And Equivalents FY 2021 · Dec 31, 2020 $15.84M
Stockholders Equity FY 2021 · Dec 31, 2021 $29.65M
Stockholders Equity FY 2021 · Dec 31, 2020 $31.41M
Stockholders Equity FY 2021 · Dec 31, 2019 $23.56M
Current Liabilities FY 2021 · Dec 31, 2021 $45.19M
Current Liabilities FY 2021 · Dec 31, 2020 $24.23M
Total Liabilities FY 2021 · Dec 31, 2021 $57.4M
Total Liabilities FY 2021 · Dec 31, 2020 $49.79M
Current Assets FY 2021 · Dec 31, 2021 $42.68M
Current Assets FY 2021 · Dec 31, 2020 $34.26M
Total Assets FY 2021 · Dec 31, 2021 $87.06M
Total Assets FY 2021 · Dec 31, 2020 $81.2M
Eps Basic FY 2021 · Dec 31, 2021 −$0.09
Eps Basic FY 2021 · Dec 31, 2020 −$0.14
Sga Expense FY 2021 · Dec 31, 2021 $30.57M
Sga Expense FY 2021 · Dec 31, 2020 $28.73M
Rd Expense FY 2021 · Dec 31, 2021 $11.11M
Rd Expense FY 2021 · Dec 31, 2020 $10.32M
Net Income FY 2021 · Dec 31, 2021 −$16.55M
Net Income FY 2021 · Dec 31, 2020 −$20.17M
Operating Income FY 2021 · Dec 31, 2021 −$15.4M
Operating Income FY 2021 · Dec 31, 2020 −$17.2M
Gross Profit FY 2021 · Dec 31, 2021 $27.25M
Gross Profit FY 2021 · Dec 31, 2020 $22.87M
Cost Of Revenue FY 2021 · Dec 31, 2021 $17.06M
Cost Of Revenue FY 2021 · Dec 31, 2020 $15.51M
Revenue FY 2021 · Dec 31, 2021 $44.31M
Revenue FY 2021 · Dec 31, 2020 $38.37M